CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0327
+0.0020 (6.62%)
At close: Apr 29, 2026

CERO Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
111269236223
Market Cap Growth
-44.29%-87.73%-83.24%-70.89%6.05%-
Enterprise Value
891470236-
Last Close Price
0.030.07120.0022000.0020540.6019820.00
PB Ratio
-0.22-0.26-6.081574.06-21.45-29.01
Debt / Equity Ratio
-0.13-0.13-0.8367.45-0.06-
Net Debt / Equity Ratio
0.160.160.8932.60-0.020.14
Net Debt / EBITDA Ratio
0.050.050.11-0.20--
Quick Ratio
0.180.180.440.430.0211.20
Current Ratio
0.300.300.500.561.3813.88
Return on Assets (ROA)
-253.00%-253.00%-178.66%-20.20%-1.63%-
Return on Capital Employed (ROCE)
366.00%366.00%1355.00%-474.00%-25.00%-0.30%
Earnings Yield
-8085.31%-1409.96%-72.13%-10.61%-0.28%-0.24%
Buyback Yield / Dilution
-16477.89%-16477.89%----
Source: S&P Capital IQ. Standard template. Financial Sources.